Insider · CIK 0001815774
Allen S. Melemed
officer
Files at CMRX (CHIMERIX INC). First filing Feb 14, 2025, latest Feb 14, 2025.
Track record
Not enough history
Fewer than three past buys with six months of prices.
Median 6-month excess
-
after past buys, n = 0
Hit rate
-
past buys that beat the index over 6 months
Open-market trades
0 / 1
$0 bought, $14k sold
Signals
This insider’s open-market buys and sells, scored.
Transactions
Every row this insider has filed, newest first.
| Date | Company | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|---|
| Apr 21, 2025 | CMRX CHIMERIX INC | DDisposition to issuer Common Stock | -173,852 | $8.55 | $1.5M | 0 | Apr 21, 2025 |
| Apr 21, 2025 | CMRX CHIMERIX INC | DDisposition to issuer Employee Stock Option (Right to Buy)derivative | -400,000 | - | - | 0 | Apr 21, 2025 |
| Apr 21, 2025 | CMRX CHIMERIX INC | DDisposition to issuer Employee Stock Option (Right to Buy)derivative | -190,000 | - | - | 0 | Apr 21, 2025 |
| Apr 21, 2025 | CMRX CHIMERIX INC | DDisposition to issuer Employee Stock Option (Right to Buy)derivative | -240,000 | - | - | 0 | Apr 21, 2025 |
| Apr 21, 2025 | CMRX CHIMERIX INC | DDisposition to issuer Employee Stock Option (Right to Buy)derivative | -154,260 | - | - | 0 | Apr 21, 2025 |
| Apr 21, 2025 | CMRX CHIMERIX INC | DDisposition to issuer Employee Stock Option (Right to Buy)derivative | -168,750 | - | - | 0 | Apr 21, 2025 |
| Apr 21, 2025 | CMRX CHIMERIX INC | DDisposition to issuer Employee Stock Option (Right to Buy)derivative | -275,000 | - | - | 0 | Apr 21, 2025 |
| Feb 13, 2025 | CMRX CHIMERIX INC | SOpen-market sale Common Stock10b5-1 | -3,065 | $4.50 | $14k | 152,875 | Feb 14, 2025 |
| Jan 7, 2025 | CMRX CHIMERIX INC | AGrant or award Common Stock | +45,925 | $0.00 | $0 | 155,940 | Jan 10, 2025 |
| Jan 7, 2025 | CMRX CHIMERIX INC | AGrant or award Stock Option (Right to Buy)derivative | +275,000 | $0.00 | $0 | 275,000 | Jan 10, 2025 |
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.